Michael Bollesen - 04 Feb 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role
Vice President of Sales
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol
MXL
Transactions as of
04 Feb 2022
Net transactions value
-$867,987
Form type
4
Filing time
08 Feb 2022, 16:33:45 UTC
Previous filing
05 Jan 2022
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Award $0 +4,921 +8.8% $0.000000 61,034 04 Feb 2022 Direct F1
transaction MXL Common Stock Tax liability $112,927 -1,817 -3% $62.15 59,217 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +4,052 +6.8% $0.000000 63,269 04 Feb 2022 Direct F2
transaction MXL Common Stock Tax liability $87,072 -1,401 -2.2% $62.15 61,868 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +2,700 +4.4% $0.000000 64,568 04 Feb 2022 Direct F2
transaction MXL Common Stock Tax liability $57,986 -933 -1.4% $62.15 63,635 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +10,797 +17% $0.000000 74,432 04 Feb 2022 Direct F3
transaction MXL Common Stock Tax liability $291,484 -4,690 -6.3% $62.15 69,742 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +7,197 +10% $0.000000 76,939 04 Feb 2022 Direct F3
transaction MXL Common Stock Tax liability $221,751 -3,568 -4.6% $62.15 73,371 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +1,885 +2.6% $0.000000 75,256 04 Feb 2022 Direct F4
transaction MXL Common Stock Tax liability $58,048 -934 -1.2% $62.15 74,322 04 Feb 2022 Direct
transaction MXL Common Stock Award $0 +1,257 +1.7% $0.000000 75,579 04 Feb 2022 Direct F4
transaction MXL Common Stock Tax liability $38,719 -623 -0.82% $62.15 74,956 04 Feb 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022.
F2 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan.
F3 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan.
F4 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan.